StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$48.58−0.66 (-1.34%)

Close on Nov 18, 2026Market cap $104.82BP/E 13.2Yield –

GSK operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was £7.74B, up 18.1% from the year before. Over ten years it grew 11.7% a year on average. The highest annual figure on record is £8.44B in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025£7.74B+18.1%
FY2024Dec 31, 2024£6.55B-3.2%
FY2023Dec 31, 2023£6.77B-8.6%
FY2022Dec 31, 2022£7.40B-6.9%
FY2021Dec 31, 2021£7.95B-5.8%
FY2020Dec 31, 2020£8.44B+5.2%
FY2019Dec 31, 2019£8.02B-4.8%
FY2018Dec 31, 2018£8.42B+21.7%
FY2017Dec 31, 2017£6.92B+6.5%
FY2016Dec 31, 2016£6.50B+152.9%
FY2015Dec 31, 2015£2.57B–

More GSK figures

See a number that looks wrong?